相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Arginase1 Deficiency in Monocytes/Macrophages Upregulates Inducible Nitric Oxide Synthase To Promote Cutaneous Contact Hypersensitivity
Jutamas Suwanpradid et al.
JOURNAL OF IMMUNOLOGY (2017)
Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics
Cullen L. Schmid et al.
CELL (2017)
The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors
Jeffrey S. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria
Tarsis F. Brust et al.
SCIENCE SIGNALING (2016)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria
Tarsis F. Brust et al.
SCIENCE SIGNALING (2016)
CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways
Yamina A. Berchiche et al.
MOLECULAR PHARMACOLOGY (2016)
Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
Ignacio Moraga et al.
CELL (2015)
Chemokine receptors as therapeutic targets: Why aren't there more drugs?
Roberto Solari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Pharmacological Characterization of [3H]VUF11211, a Novel Radiolabeled Small-Molecule Inverse Agonist for the Chemokine Receptor CXCR3
Danny J. Scholten et al.
MOLECULAR PHARMACOLOGY (2015)
CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis (Publication with Expression of Concern. See vol. 128, pg. 1200, 2018) (Publication with Expression of Concern. See vol. 127, pg. 3913, 2017)
Yaniv Zohar et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Multicenter Phase II Study of Mogamulizumab ( KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Michinori Ogura et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers
David G. Soergel et al.
PAIN (2014)
CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
Mehdi Rashighi et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium
Michelle M. Monasky et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors
Sudarshan Rajagopal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein
Julie Quoyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3
D. J. Scholten et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Chemical Subtleties in Small-Molecule Modulation of Peptide Receptor Function: The Case of CXCR3 Biaryl-Type Ligands
Maikel Wijtmans et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
TGFα shedding assay: an accurate and versatile method for detecting GPCR activation
Asuka Inoue et al.
NATURE METHODS (2012)
β-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway
Heddie L. Nichols et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
CXCR3 ligands: redundant, collaborative and antagonistic functions
Joanna R. Groom et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways
Luke J. Drury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Thomas J. Schall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
β-Arrestins Scaffold Cofilin with Chronophin to Direct Localized Actin Filament Severing and Membrane Protrusions Downstream of Protease-activated Receptor-2
Maria Zoudilova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
An arrestin-dependent multi-kinase signaling complex mediates MIP-1β/CCL4 signaling and chemotaxis of primary human macrophages
Ricky Cheung et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance
Bing Luan et al.
NATURE (2009)
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
David A. Zidar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice
Eva J. A. Van Wanrooij et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
CXCR4 dimerization and β-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
Bernard Lagane et al.
BLOOD (2008)
A β-arrestin 2 signaling complex mediates lithium action on Behavior
Jean-Martin Beaulieu et al.
CELL (2008)
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
Matthew T. Drake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inhibition of Gαi2 activation by Gαi3 in CXCR3-mediated signaling
Brian D. Thompson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries
Ilana L. Stroke et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis
Richard A. Colvin et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
β-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis
DL Hunton et al.
MOLECULAR PHARMACOLOGY (2005)
Monitoring agonist-promoted conformational changes of β-arrestin in living cells by intramolecular BRET
PG Charest et al.
EMBO REPORTS (2005)
Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor
SK Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function
RA Colvin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Differential desensitization, receptor phosphorylation, β-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7
TA Kohout et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A β-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis
L Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequence of ERK activation
A Tohgo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nickel-specific CD4+ and CD8+ T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis
S Sebastiani et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Defective lymphocyte chemotaxis in β-arresting2-and GRK6-deficient mice
AM Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells
M Morales-Ruiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Human interferon-inducible 10-kDa protein and human interferon-inducible T cell α chemoattractant are allotopic ligands for human CXCR3:: Differential binding to receptor states
MA Cox et al.
MOLECULAR PHARMACOLOGY (2001)
Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes
A Bonacchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)
S Angers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
